# Arcus Biosciences, Inc. (RCUS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RCUS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 17.00M | $ -128.00M | $ -138.00M | $ 100.00M | $ 524.00M |
| 2025 | $ 252.91M | $ -361.44M | $ -495.57M | $ 99.00M | $ 631.00M |
| 2024 | $ 271.18M | $ -297.46M | $ -184.99M | $ 60.00M | $ 485.00M |
| 2023 | $ 126.51M | $ -331.94M | $ -356.81M | $ 11.00M | $ 462.00M |
| 2022 | $ 124.73M | $ -298.78M | $ 476.80M | $ 120.00M | $ 657.00M |
| 2021 | $ 455.11M | $ 62.80M | $ -335.50M | $ 121.99M | $ 841.45M |
| 2020 | $ 98.75M | $ -156.51M | $ 137.73M | $ 18.11M | $ 502.30M |
| 2019 | $ 19.36M | $ -109.34M | $ -97.31M | $ 0 | $ 163.84M |
| 2018 | $ 11.03M | $ -65.50M | $ -61.73M | $ 0 | $ 234.94M |
| 2017 | $ 1.90M | $ -71.51M | $ -41.19M | $ 0 | $ 153.87M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.19 |
| Liabilities / Eq | 0.90 |
| Current Ratio | 4.04 |

## Other views

- [Metrics](https://sponda.capital/en/RCUS.md)
- [Charts](https://sponda.capital/en/RCUS/charts.md)
- [Compare](https://sponda.capital/en/RCUS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.